A B S T R A C T The purified lymphocytosis promoting factor (LPF) from Bordetella pertussis was found to be a potent mitogen for peripheral blood lymphocytes (PBL) PBL from most patients with chronic lymphatic leukemia and lymphosarcoma cell leukemia were even less responsive to LPF than to phytohemagglutinin, whereas PBL from patients with lymphosarcoma usually responded to both mitogens. It can be inferred from the results of experiments with both normal and leukemic cells that LPF, which is a murine thymtusderived (T)-cell mitogen, is also a T-cell mitogen for human PBL. The exact cell requirement and mode of action, however, are as yet unknown.
A B S T R A C T The purified lymphocytosis promoting factor (LPF) from Bordetella pertussis was found to be a potent mitogen for peripheral blood lymphocytes (PBL) from normal adults as well as for cord blood lymphocytes. Proliferation occurred in autologous plasma or fetal calf serum, regardless of previous exposure to pertussis infection or immunization. Only one adult human serum, from a physician constantly working with B. perttissis, inhibited the mitogenic response to LPF and this serum was shown to contain precipitating antibody against LPF. The proliferative effect of LPF was characteristic of a "nonspecific" mitogen and not of antigen stimulation of sensitized cells.
LPF, phytohemagglutinin, and concanavalin A were approximately equal in potency although variation occurred depending upon the cell donor. Experiments with lymphocyte subpopulations obtained by rosetting techniques employing sheep erythrocytes, mouse erythrocytes, and sheep erythrocytes coated with antibody and complement suggested the requirement of a mtulticellular system for LPF mitogencity.
PBL from most patients with chronic lymphatic leukemia and lymphosarcoma cell leukemia were even less responsive to LPF than to phytohemagglutinin, whereas PBL from patients with lymphosarcoma usually responded to both mitogens. It can be inferred from the results of experiments with both normal and leukemic cells that LPF, which is a murine thymtusderived (T)-cell mitogen, is also a T-cell mitogen for human PBL. The exact cell requirement and mode of action, however, are as yet unknown.
INTRODUCTION
The association of peripheral blood lymphocytosis with clinical pertussis (whooping cough) has long been known (1) . Both intact Bordetella pertussis organiSms and culture supernatant fluids induce lymphocytosis in mice and many other experimental animals (2) . Recently, the lymphocytosis promoting factor (LPF)' has been purified from B. pertussis culture supernatant fluids (3) . In addition to its in vivo effects, LPF was found by Kong and Mlorse (4, 5) to be a potent mitogen for murine lymphocytes in vitro. LPF stimulated cells from lymph nodes and spleen but not from the thymus or bone marrow. The mitogenic response of murine lymphocytes to LPF was the result of activation of unsensitized T cells, but there was a requirement for an accessory nonphagocytic adherent cell (6) . Furthermore, the subpopulation T cell responding to LPF was different from that stimulated by phytohemagglutinin (PHA) or concanavalin A (Con A).
The present studies were initiated to determine whether LPF was mitogenic for normal and abnormal human peripheral blood lymphocytes (PBL) , and to identify the responding lymphocyte population.
Lymphocyte cultures PBL were isolated from heparinized venous blood by a modification of the method of Boyum (7) . 40-50 ml of blood were obtained from normal individuals in phenol-free heparin and allowed to sediment at 37°C for 1-2 h. The plasma was expressed from the top of the syringe and gently mixed with an equal volume of sterile isotonic saline. 2 vol of the saline-plasma soltution were layered over 1 vol of Ficoll-Conray solution (10 ml 33.4% Conray, megltumine iothalamate, prepared from a 60% aqueous solution + 24 ml 9% Ficoll) and centrifuged for 30 miim at 40C (Ficoll was from Pharmacia Fine Chemicals, Piscataway, N. J.. and 60% Conray was from Mallinckrodt Inc., St. Louis, Mo.). The interface was removed and washed three times with RPMI 1640 (Grand Island Biological Co., Grand Island, N. Y.) supplemented with 50 U/ml penicillin, 50 ,g/ml streptomycin, and 2 mM L-glutamine. tUsually 85% of the cells were lymphocytes and 15% monocvtes. The trvpan blue dye viability was >95%. The cells were cultured in this medium with 5% fetal calf serum (FCS; Grancl Island Biological Co.), 10% pooled human AB plasma, or 10% autologous plasma. Except for autologous systems, all sera and plasma were heated to 56°C for 30 min before utse.
Triplicate cultuires of 0.25 ml containing 1 or 2 x 105 lymphocytes per well were placed in microtiter plates (Linbro IS FB96, Linbro Chemical Co., New Haven, Conn.), and incubated at 37°C in 5% C02:95% air for various time periods. The cultures were then pulsed overnight with 1 ,ugCi/well of [3H]thymidine, 6.7 Ci/mmol (New England Nuclear, Boston, Mass.). The microtiter cultures were harvested and washed extensively with saline on glass fiber filters (grade 934 AH, Reeve Angel, Clifton, N. J.) using a Mash II Harvester (Microbiological Associates, Bethesda, Md.; 8). The filters were dried and placed in 12 ml of Instabray (Yorktown Research Inc., S. Hackensack, N. J.).
3H content was determined in a liqtuid scintillation spectrometer (Packard model 3320, Packard Instrument Co., Inc., Downers Grove, Ill.). The results are expressed as mean cpm of triplicate samples.
Mitogens
The mitogens used included LPF, PHA-P and Con A. LPF was purified by methods previously described (3) . Because it is kept in uirea, the LPF controls initially contained the exact amount of urea for all LPF concentrations, but inasmuch as these conitrols showed similar counting rates to the resting unstimulated cultures, the later experiments utsed only the amounit of uirea corresponding to the highest concentrations of LPF. All preparations of LPF were tested for mitogenicity oni mturine lymphocytes before uise on human PBL. Dose-response curves with PHA-P and Con A were p)erformed in a previouis study (9) , and all normal individuals responded to the two doses of each mitogen selected to serve as positive controls for mitogen lymphocyte stimuilation. Peak stimulation with both mitogens occutrred at 5 days. The cuiltuires contained either 0.001 or 0.005 ml stock/ ml PHA-P (Difco Laboratories, Detroit, Mlich.) or 1, 5 and occasionally 50 Ag/ml Con A (Calbiochem, Sani Diego, Calif.).
Lymphocyte rosette techniques
Shee) red blood cell (SRBC) rosettes (E). A modification of the method of \Vylhran et al. (10) was used to obtain lymphocytes with receptors for SRBC. Equal volumes of a 2 x 106/ml lymphocyte suspenision were incubated for 15 min at 37°C with 0.5% SRBC (the SRBC hald been stored in Alsever's soluition for 1-3 wk). After centriftging at 200g the pellet was gently overlaid with 0.2-0.4 ml of FCS, wllich had been absorbed against SRBC before use, andl incubated at 4°C for >1 h. The pellet was gently resuspended and an aliquot removed to count the percent of SRBC (+) rosettes. A rosette was definecl as a lymphocyte with three or more adherent SRBCs. The remlaining rosettes wsere p)laced on a Ficoll-Conray gradient, centrifuged, and the heavcy rosetted lymphocytes and those lcft at the interfhace were harvested separately. After washinig and lysing the SRBC, the cell concentrations were e(qutalized and in somile experiments reconstitulted in varying ratios of E (+) to E (-) cells.
Antigen-antibody-o mpl1)le tnent com)lex (EA C) rosettes. Fig. 1 , it can also be seen that LPF produced comparable or even greater stimtulation of normal PBL when compared with the responses to two concentrations of PHA-P and Con A. These resuilts are illtustrated more extensively in Table I wlhichl shows the level of lymphocyte stimtulation by LPF and PHA-P tising PBL from 19 normal adult individuals over 20 yr of age. In initial experiments 10-15% auitologous plasma was uised, and it wvas anticipated that antiperttussis antibody restulting from immtunization with DPT or childhood perttussis (wlhooping couigh) might inhibit LPF stimtulation. The uipper section of Table I shows the results witlh the PBL of seven individtuals which were ctulttured in auitologouis plasma. Two had no known immunization or clinical history of pertuissis; three had a childhood history compatible with perttussis; and two received childhood DPT immtunization. All PBL had a ftull response to LPF in autologouis plasma except those from subject S.IM.. As shown in The results of a representative experiment are shown in Fig. 5 . It can be seen that neither E(+) cells nor E(-) cells alone were capable of responding optimally to LPF when compared to the stimulation obtained with unseparated cells. In contrast, the reconstituted population of 80% E(+) and 20%o E(-) cells reacted normally. The E(+) population gave 20,000 cpm or approximately one-third of the maximum LPF stimulation of 60,000 cpm, whereas the E(-) cells gave 5,000 cpm or only about one-twelfth of maximal stimulation. In contrast to LPF, PHA proved fully mitogenic for the E(+) cells as well as for the unseparated cells and the reconstituted cells, but like LPF was only minimally mitogenic for the E(-) cells.
Individual variations occurred with the PBL from four normal individuals examined in this manner, but the inability of the isolated SRBC receptor-positive maximum stimulation was greater in the older preparation of LPF which is consonant with the finding in the murine system that LPF loses its mitogenicity upon prolonged storage, presumably as a result of aggregation.
The fact that PBL from all normal adults tested responded to LPF in antibody-free medium suggested that LPF, although derived from an organism with which most individuals have had contact, either as immunogen or pathogen, was not causing lymphocyte proliferation on the basis of antigen stimulation of previously sensitized lymphocytes. Moreover, with the exception of S.I.M., no serological evidence of prior LPF exposure could be found. Nevertheless, in order to rigorously exclude the possibility that sensitized cells were the responders, cord blood lymphocytes were tested for stimulation by LPF. As shown in Table II Comparison of the mitogenicity of two different preparations of LPF. LPF preparation no. 32 was more than 3 wk older than preparation no. 33 at the time of assay. LPF concentrations are expressed as ,ug/ml; PHA as ml/ml; and Con A as ,ug/ml of culture. PBL were separated into SRBC positive, E(+), and SRBC negative E(-) populations as well as recombined in a ratio of 80% E(+) and 20% E(-). The cell concentrations for all four groups were 5 x 105/ml. The initial ratio of the unseparated cells was 60% E(+) and 40% E(-).
cells to respond to LPF was consistent, whereas there was a fill PHA effect. PBL were next separated on the basis ofthe presence, EAC(+), or absence, EAC(-), of receptors for mouse C. SRBCs were coated with 19S rabbit anti-SRBC antibody and mouse C by the technique of Bianco et al. (12) , and the rosettes placed on Ficoll-Conray density gradient. This technique selected out B lymphocytes with C receptors, EAC(+), leaving behind monocytes and all the lymphocytes lacking C receptors, EAC(-). Effect of LPF and PHA on normal PBL separated by rosetting techniques with EAC. PBL were separated into those with receptors for mouse C using EAC(+), and those lacking these receptors, EAC(-). These two populations were also recombined in an 80% EAC(-) and 20% EAC(+) ratio.
The cell concentration in all four groups was 8 x 105/ml. The initial ratio of the uinseparated cells was 86% EAC(-) and 14% EAC(+). Although not plotted, a 60% EAC(-) and 40% EAC(+) ratio produced similar [3H]thymidine incorporation to the 80% EAC(-) and 20% EAC(+) ratio.
for mouse erythrocytes were isolated by the rosetting technique. This method selects for lymphocytes containing surface immunoglobulin (11) . In the experiment illustrated in Fig. 7 
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as the Em&(-) population alone gave approximately one-third the maximal response. As in the case of E(+) and E(-) cells, neither isolated population was capable of responding to LPF, suggesting that a complex interaction of cells was required for mitogenicity. Fairly good mitogenic responses were obtained with PHA in all groups except for those cells with receptors for MRBCs, which are presumably B lymphocytes containing surface immunoglobulin. Mitogenic effect of LPF on PBL from patients with chronic lymphatic leukemia (CLL), lymphosarcoma cell leukemia (LSCL), and lymphosarcoma (LSA).
PBL from 23 patients with peripheral blood lymphocytosis associated with CLL, LSCL, and LSA were isolated by gradient centrifugation by the same method used for obtaining normal PBL and then cultured in FCS. These 23 patients were divided into three clinical groups illustrated in Table III . 13 had CLL, 5 LSCL, and 5 LSA.
Groups I and II had CLL and chronic LSCL as defined morphologically and clinically by Zacharski and Linman (13) . In four of the patients in group III (Table III) , the illness began as a disorder presenting with lymph node enlargement (biopsy proved as lymphocytic LSA) without increased numbers of circulating lymphocytes and later progressed to a phase in which increasing numbers of abnormal lymphocytes were found in the peripheral blood (14) . In case 21, the illness initially presented with increased numbers of LSA cells in the peripheral blood without organ involvement (stage 0 according to the classification of Rai et al. (15) . At the time of study 23 yr later, after multiple courses of therapy with alkylating agents, the patient had minimal involvement of the peripheral blood with periodic massive enlargement of cervical and inguinal lymph nodes. The patients were placed in these three groups by one of us (J.L.) without knowledge of the results of mitogen studies. Note that most patients with CLL were not receiving therapy at the time of testing, unlike those with LSA. One PHA-responsive patient later became unresponsive. Four of five individuals with LSA had normal or near normal responses to both mitogens. The one unresponsive patient (no. 23) in this group was unusual in that she had a histologic diagnosis of a nodular, well-differentiated lymphocytic LSA, whereas the other four had poorly differentiated lymphocytic LSAs.
Of the 18 patients with CLL or LSCL, only 3 responded to LPF whereas 9 responded to PHA. Thus PHA is more likely to give a mitogenic response in this group of B-cell leukemias, and LPF may be a more useful mitogen than PHA in identifying these patients. Both LPF and PHA were mitogenic for the PBL of LSA patients with poorly differentiated LSAs, however these patients were also on chemotherapy.
It can also be noted in Table IV Two patients with Sezary syndrome were tested because this is a T-cell leukemia (16) . One was tinresponsive to both LPF and PHA with counting rates below 600 cpm, whereas the other responded weakly with maximal responses ranging between 1,400 and 1,900 cpm for both mitogens. Although other leukemias were not systematically investigated, one patient with chronic myelogenotus leuikemia responded normally to both mitogens.
DISCUSSION
The product of Bordetella pertuissis which cauises leukocytosis with a predominance of matture-appearing small lymphocytes has recently been isolated and characterized (3) . The purified LPF was found to be a potent, nonspecific mitogen for mouse T lymphocytes (6) .
The experiments performed in this study were designed to determine (a) whether LPF is a mitogen for human lymphocytes, (b) whether the mitogenic effect is related to prior exposure to antigen, (c) the comparative effects of LPF, PHA, and CoIn A on lymphocyte populations, and (d) the nature of the responding cells.
PBL from six of seven aduilts were stimulated by Lymphocytosis Promoting Factor on Lymphocytes 
